Toward Control? The Prospects and Challenges of Typhoid Conjugate Vaccine Introduction

Area of Science:

• Public Health
• Vaccinology
• Infectious Disease Control

Background:

• Typhoid fever remains a significant global health burden, exacerbated by increasing antimicrobial resistance.
• The development of a World Health Organization (WHO)-prequalified typhoid conjugate vaccine (TCV) marks a critical advancement.
• Existing typhoid control strategies require enhancement to address evolving challenges.

Purpose of the Study:

• To advocate for the timely introduction of TCVs into national immunization programs.
• To highlight the importance of integrating TCVs within comprehensive typhoid control strategies.
• To emphasize the need for strategic planning and community engagement for successful TCV deployment.

Main Methods:

• This is a policy and strategic recommendation, not a research study.
• Analysis of current global health landscape regarding typhoid fever.
• Review of recent advancements in vaccine technology and global health funding.

Main Results:

• A WHO-prequalified TCV is now available, supported by Gavi funding.
• WHO has issued a policy recommendation for the use of TCVs.
• Antimicrobial resistance is increasing the urgency for effective typhoid interventions.

Conclusions:

• Countries should prioritize the introduction of TCVs as part of integrated typhoid control programs.
• Continued vaccine development and ongoing studies are crucial for securing low-cost vaccines and optimizing deployment strategies.
• Effective communication and community engagement are essential to address vaccine hesitancy and ensure program success.